Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Buy
149
+147
+7,350% +$10.6K 0.01% 1450
2026
Q1
$0 Sell
2
-1
-33% -$68 ﹤0.01% 2605
2025
Q4
$0 Hold
3
﹤0.01% 2580
2025
Q3
$0 Hold
3
﹤0.01% 2593
2025
Q2
$0 Hold
3
﹤0.01% 2561
2025
Q1
$0 Hold
3
﹤0.01% 2555
2024
Q4
$0 Buy
3
+2
+200% +$83 ﹤0.01% 2562
2024
Q3
$0 Sell
1
-1
-50% -$40 ﹤0.01% 2559
2024
Q2
$0 Sell
2
-3
-60% -$145 ﹤0.01% 2572
2024
Q1
$0 Sell
5
-1,006
-100% -$45.2K ﹤0.01% 2567
2023
Q4
$48K Buy
1,011
+381
+60% +$15.8K 0.03% 874
2023
Q3
$30K Buy
630
+91
+17% +$4.97K 0.02% 984
2023
Q2
$31K Buy
539
+537
+26,850% +$32.2K 0.02% 977
2023
Q1
$0 Sell
2
-875
-100% -$69.5K ﹤0.01% 2390
2022
Q4
$62K Buy
877
+150
+21% +$10.6K 0.05% 634
2022
Q3
$44K Buy
727
+722
+14,440% +$48.4K 0.04% 742
2022
Q2
$0 Sell
5
-3
-38% -$196 ﹤0.01% 2199
2022
Q1
$1K Sell
8
-174
-96% -$11.6K ﹤0.01% 1896
2021
Q4
$13K Buy
+182
New +$13.8K 0.02% 951

Other funds holding NGVT

Covestor's NGVT Position: Q2 2026 in Review

Covestor increased its Ingevity (NGVT) stake by 7,350% in Q2 2026, buying an estimated $10.6K and bringing the position to 149 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #1450.

Covestor first reported a position in NGVT in Q4 2021 and has held it in 19 quarters since. The position peaked at $62K in Q4 2022. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Covestor held 149 shares of Ingevity worth $12K as of Q2 2026.
  • Covestor bought 147 Ingevity shares in Q2 2026, an estimated $10.6K.
  • Ingevity made up 0.01% of Covestor's portfolio in Q2 2026, its #1450 holding.
  • Covestor first reported a position in Ingevity in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Ingevity position peaked at $62K in Q4 2022.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.